santé – Covid - pour une diversification vaccinale !

This written question asks about the French government's strategy for diversifying COVID-19 vaccines. It seeks to understand the rationale behind vaccine choices and future procurement plans. The question highlights concerns about reliance on a limited number of vaccine manufacturers and explores the potential benefits of a broader portfolio for public health.